Visentin R - Search Results

1

Technetium-99m labeling of N-[N-(3-diphenylphosphino propionyl)glycyl]cysteine (PN2S-OH) and its methyl ester derivative (PN2S-OMe).

Visentin R, Giron MC, Bello M, Mazzi U. Visentin R, et al. Nucl Med Biol. 2004 Jul;31(5):655-62. doi: 10.1016/j.nucmedbio.2004.02.001. Nucl Med Biol. 2004. PMID: 15219285

2

Synthesis and characterization of rhenium(V) oxo complexes with N-[N-(3-diphenylphosphinopropionyl)glycyl]cysteine methyl ester. X-ray crystal structure of (ReO[Ph(2)P(CH(2))(2)C(O)-Gly-Cys-OMe(P,N,N,S)]).

Visentin R, Rossin R, Giron MC, Dolmella A, Bandoli G, Mazzi U. Visentin R, et al. Inorg Chem. 2003 Feb 24;42(4):950-9. doi: 10.1021/ic025859r. Inorg Chem. 2003. PMID: 12588125

3

Highly efficient technetium-99m labeling procedure based on the conjugation of N-[N-(3-diphenylphosphinopropionyl)glycyl]cysteine ligand with poly(ethylene glycol).

Visentin R, Pasut G, Veronese FM, Mazzi U. Visentin R, et al. Bioconjug Chem. 2004 Sep-Oct;15(5):1046-54. doi: 10.1021/bc049896d. Bioconjug Chem. 2004. PMID: 15366958

4

99mTc-labeling experiments on CCK(4) by a direct method.

Rossin R, Blok D, Visentin R, Feitsma RI, Giron MC, Pauwels EK, Mazzi U. Rossin R, et al. Among authors: visentin r. Nucl Med Biol. 2001 Oct;28(7):865-73. doi: 10.1016/s0969-8051(01)00254-2. Nucl Med Biol. 2001. PMID: 11578909

5

In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging.

Aloj L, Panico M, Caraco C, Del Vecchio S, Arra C, Affuso A, Accardo A, Mansi R, Tesauro D, De Luca S, Pedone C, Visentin R, Mazzi U, Morelli G, Salvatore M. Aloj L, et al. Among authors: visentin r. Cancer Biother Radiopharm. 2004 Feb;19(1):93-8. doi: 10.1089/108497804773391739. Cancer Biother Radiopharm. 2004. PMID: 15068617

6

CCK8 peptide derivatized with diphenylphosphine for rhenium labelling: synthesis and molecular mechanics calculations.

Morelli G, De Luca S, Tesauro D, Saviano M, Pedone C, Dolmella A, Visentin R, Mazzi U. Morelli G, et al. Among authors: visentin r. J Pept Sci. 2002 Jul;8(7):373-81. doi: 10.1002/psc.400. J Pept Sci. 2002. PMID: 12148786

7

Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.

Welling MM, Visentin R, Feitsma HI, Lupetti A, Pauwels EK, Nibbering PH. Welling MM, et al. Among authors: visentin r. Nucl Med Biol. 2004 May;31(4):503-9. doi: 10.1016/j.nucmedbio.2003.11.009. Nucl Med Biol. 2004. PMID: 15093821

8

Smart Algorithms for Efficient Insulin Therapy Initiation in Individuals With Type 2 Diabetes: An in Silico Study.

Bonet J, Visentin R, Dalla Man C. Bonet J, et al. Among authors: visentin r. J Diabetes Sci Technol. 2024 Apr 22:19322968241245930. doi: 10.1177/19322968241245930. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 38646824 Free PMC article.

9

Short- and Long-Term Effects on Glucose Control of Nonadherence to Insulin Therapy in People With Type 2 Diabetes An In Silico Study.

Visentin R, Cobelli C, Sieber J, Dalla Man C. Visentin R, et al. J Diabetes Sci Technol. 2024 Mar;18(2):309-317. doi: 10.1177/19322968231223936. Epub 2024 Jan 29. J Diabetes Sci Technol. 2024. PMID: 38284154

10

Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations.

Visentin R, Schiavon M, Bonet J, Riz M, Wagenhuber B, Man CD. Visentin R, et al. IEEE Trans Biomed Eng. 2024 Jun;71(6):1780-1788. doi: 10.1109/TBME.2024.3352153. Epub 2024 May 20. IEEE Trans Biomed Eng. 2024. PMID: 38198258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters